News and Publications

When faced with a life-threatening diagnosis of malignant mesothelioma, the patient and his or her loved ones will certainly seek the most advanced medical care to ensure the best possible outcome.  Memorial Sloan-Kettering Cancer Center is at the...

Galiher DeRobertis & Waxman has represented clients with mesothelioma and lung cancer resulting from asbestos exposure for the past 30 years.   Some of our clients have participated in clinical trials that test new combinations of surgery, radiation and...

Today, cancer is the leading cause of death worldwide.  It is estimated that the number of cancer deaths around the world is expected to rise by 45 percent between 2007 to 2030.  However, experts now claim that as...

During 2009, the National Institutes of Health (NIH) received significant financial support for very important research underway in the area of genome mapping.  This work may ultimately lead to more effective treatments, and ultimately cures, for many types...

DNA double helix In 1953, two British researchers, James D. Watson and Francis Crick, won the race to a Nobel Prize by unlocking the structure of DNA (deoxyribonucleic acid).  Watson and Crick discovered the double-helix, made up of...

Malignant mesothelioma is a rare disease in the general population.  About one person per million contracts this aggressive cancer, which is caused by exposure to asbestos products.  By way of comparison, about 215,000 people were diagnosed with lung...

Lung cancer, like asbestosis and mesothelioma, can be caused by exposure to asbestos.  Many who suffer from lung cancer and mesothelioma have to undergo invasive procedures when being diagnosed.  However, new procedures are being developed to test for...

Treatment of malignant mesothelioma has been extremely difficult.  Not only is malignant mesothelioma resistant to most forms of chemotherapy drugs, but even when the mesothelioma tumor responds to the standard protocol of treatment with Alimta (Pemetrexed) and Cisplatin,...